| Cash Flow | 2025-06-30 |
|---|---|
| Net loss for the period | -1,057,431 |
| Accrued board of directors compensation | 211,500 |
| Accounts payable and accrued expenses | 1,630 |
| Loss on liability settlement | -801,193 |
| Net cash flows used in operating activities | -43,108 |
| Proceeds from related parties | 43,151 |
| Capital contributions | 0 |
| Net cash flows provided by financing activities | 43,151 |
| Cash flows from investing activities | 0 |
| Net change in cash | 43 |
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)